TY  - JOUR
T1  - Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV16/18) prophylactic HPV vaccines
A1  - Syrjänen,K.
JO  - European Journal of Gynaecological Oncology
VL  - 32
IS  - 1
SP  - 17
EP  - 33
SN  - 2709-0086
Y1  - 2011
ER  -